Intracoronary drugs during percutaneous interventions: the highway has different lanes!

J Cardiovasc Med (Hagerstown). 2011 Apr;12(4):303-4. doi: 10.2459/JCM.0b013e32833e8b70.
No abstract available

Publication types

  • Letter

MeSH terms

  • Angioplasty, Balloon, Coronary*
  • Drug Administration Routes
  • Hemorrhage / chemically induced
  • Humans
  • Patient Selection
  • Platelet Aggregation Inhibitors / administration & dosage*
  • Platelet Aggregation Inhibitors / adverse effects
  • Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors
  • Risk Assessment
  • Risk Factors
  • Treatment Outcome

Substances

  • Platelet Aggregation Inhibitors
  • Platelet Glycoprotein GPIIb-IIIa Complex